Kentucky Drug Laws: Penalties, Charges & Treatment Options

Kentucky's drug laws are codified primarily in KRS Chapter 218A — the Kentucky Controlled Substances Act. The state classifies controlled substances into five schedules (I through V), with Schedule I drugs carrying the highest abuse potential and no accepted medical use, and Schedule V drugs having the lowest abuse potential.

Kentucky distinguishes between possession offenses and trafficking offenses. Possession of a controlled substance in the first degree (KRS 218A.1415) applies to Schedule I and II narcotics and is a Class D felony. Second-degree possession (KRS 218A.1416) covers non-narcotic Schedule I, II, and III substances and is a Class A misdemeanor for a first offense. Third-degree possession (KRS 218A.1417) covers Schedule IV and V substances.

Trafficking penalties are significantly more severe. First-degree trafficking under KRS 218A.1412 applies to cocaine (4+ grams), methamphetamine (2+ grams), heroin, fentanyl, and carfentanil in any quantity, and is a Class C felony for a first offense (5-10 years). Persons convicted of trafficking heroin, fentanyl, or carfentanil at the Class C felony level or higher must serve at least 50% of their sentence before becoming eligible for parole or early release.

Marijuana trafficking is addressed separately under KRS 218A.1421, with penalties escalating based on quantity. Possession of marijuana (KRS 218A.1422) for less than 8 ounces is a Class B misdemeanor for a first offense, with a maximum 45-day jail sentence and $250 fine.

In 2023, Governor Andy Beshear signed Senate Bill 47, legalizing medical cannabis in Kentucky effective January 1, 2025. The program permits non-smokable cannabis products for patients with qualifying conditions. Recreational marijuana remains illegal. Kentucky also enacted House Bill 829 in 2024 to expedite licensing for cannabis businesses.

Kentucky has enacted harm reduction measures including the Good Samaritan law (KRS 218A.133) and naloxone access provisions (KRS 217.186), reflecting the state's response to the ongoing opioid crisis that has hit Appalachian Kentucky particularly hard.

Possession of Controlled Substances in Kentucky

First-Degree Possession (KRS 218A.1415)

A person is guilty of possession of a controlled substance in the first degree when they knowingly and unlawfully possess a controlled substance that is classified in Schedules I or II and is a narcotic drug, or is a controlled substance analogue. This is a Class D felony punishable by 1 to 5 years in prison and a fine up to $10,000.

For a first or second offense, defendants are eligible for deferred prosecution (preferred for first offenses) or presumptive probation. The court shall require participation in a substance abuse treatment program as a condition.

Second-Degree Possession (KRS 218A.1416)

Covers possession of non-narcotic Schedule I or II substances (e.g., amphetamines, MDMA) and Schedule III substances (e.g., anabolic steroids, ketamine). A first offense is a Class A misdemeanor (up to 12 months, $500 fine). A second or subsequent offense is a Class D felony (1-5 years).

Third-Degree Possession (KRS 218A.1417)

Covers possession of Schedule IV or V substances (e.g., benzodiazepines, certain cough preparations). This is a Class A misdemeanor for all offenses.

Marijuana Possession (KRS 218A.1422)

Possession of less than 8 ounces of marijuana is a Class B misdemeanor for a first offense, punishable by up to 45 days in jail and a $250 fine. A second or subsequent offense is a Class A misdemeanor. Possession outside of the medical cannabis program remains illegal.

Assessment and Treatment (KRS 218A.275, KRS 218A.276)

Kentucky law mandates substance abuse assessment and treatment for persons convicted of certain drug possession offenses. Courts may require completion of a certified drug treatment program as a condition of probation or deferred prosecution.

Kentucky DUI Laws (KRS 189A.010)

Kentucky prohibits operating a motor vehicle while under the influence of alcohol, any controlled substance, or any other substance that impairs driving ability. The legal BAC limit is 0.08% (0.02% for drivers under 21). For drug-impaired driving, Kentucky uses an impairment standard rather than a per se drug concentration limit.

First Offense

• Jail: 48 hours to 30 days (mandatory minimum 48 hours; 4 days with aggravating circumstances)
• Fine: $200 to $500
• License suspension: 30 to 120 days
• Other: Community service of 48 hours to 30 days may substitute for jail; alcohol/substance abuse treatment program required; 90-day ignition interlock option

Second Offense (within 10 years)

• Jail: 7 days to 6 months (mandatory minimum 7 days; 14 days with aggravating circumstances)
• Fine: $350 to $500
• License suspension: 12 to 18 months
• Other: Mandatory substance abuse treatment; 12-month ignition interlock device

Third Offense (within 10 years)

• Jail: 30 days to 12 months (mandatory minimum 30 days; 60 days with aggravating circumstances)
• Fine: $500 to $1,000
• License suspension: 24 to 36 months
• Other: Mandatory substance abuse treatment; 30-month ignition interlock device

Fourth or Subsequent Offense (within 10 years)

• Classification: Class D Felony
• Prison: 1 to 5 years (mandatory minimum 120 days)
• Fine: $1,000 to $10,000
• License suspension: 60 months

Aggravating Circumstances

Under KRS 189A.010(11), aggravating factors include: BAC of 0.15% or higher, excessive speed (30+ mph over limit), wrong-way driving, causing an accident resulting in injury or death, transporting a passenger under age 12, and refusing a chemical test.

Kentucky Naloxone Access Law (KRS 217.186)

Kentucky has enacted comprehensive naloxone access provisions to combat opioid overdose deaths.

Prescribing and Distribution

• A prescriber may prescribe naloxone directly or by standing order to any person or agency the prescriber believes is capable of administering the drug in an overdose emergency (KRS 217.186).
• Prescriptions may authorize another person to administer naloxone to the person to whom it is prescribed.
• Pharmacists with appropriate certification may dispense naloxone under a physician-approved protocol.
• Naloxone may be provided to agencies that train the public in its administration.

Permitted Formulations

Kentucky law authorizes intranasal naloxone (e.g., Narcan nasal spray) and auto-injector naloxone (e.g., Evzio).

Civil and Criminal Immunity

Any person acting in good faith who administers naloxone they have lawfully obtained is immune from criminal and civil liability, except in cases of gross negligence or willful or wanton misconduct.

State Initiatives

The Kentucky Office of Drug Control Policy (ODCP) operates the Stop Overdoses program, which distributes naloxone kits and provides overdose prevention training across the commonwealth. Kentucky has been one of the hardest-hit states in the opioid epidemic, with particular impact in Appalachian communities.

Kentucky Drug Courts (KRS 26A.400 et seq.)

Kentucky's drug court program is authorized under KRS 26A.400 and is administered as part of the state's specialty court system under the Kentucky Court of Justice.

Program Scope

Kentucky operates over 80 specialty courts across the commonwealth, including adult drug courts, juvenile drug courts, DUI courts, mental health courts, and veterans treatment courts. Drug courts have been certified in 34 or more counties, covering a significant portion of the state's population.

Eligibility

• Individuals charged with nonviolent felony or misdemeanor offenses related to substance use
• Must be eligible for diversion and/or probation
• Must be identified by validated screening tools as high risk and high need
• Violent offenses and certain trafficking charges are generally excluded

Program Components

• Judicial supervision with frequent status hearings
• Mandatory substance abuse treatment and counseling
• Random and frequent drug testing
• Graduated sanctions and incentives
• Community service requirements
• Vocational and educational assistance

Outcomes

Kentucky's specialty courts aim to provide equitable pathways to recovery that divert justice-involved individuals into treatment and out of the traditional court system, reducing recidivism and incarceration costs.

Mandatory Minimum Sentences in Kentucky Drug Cases

Trafficking in Heroin, Fentanyl, or Carfentanil (KRS 218A.1412)

Any person convicted of a Class C felony or higher for trafficking in heroin, fentanyl, carfentanil, or fentanyl derivatives must serve at least 50% of their sentence before becoming eligible for probation, shock probation, parole, conditional discharge, or any other form of early release.

Repeat Trafficking Offenses

A second or subsequent conviction for first-degree trafficking (KRS 218A.1412) elevates the offense from a Class C to a Class B felony (10-20 years), creating a de facto mandatory minimum of 10 years.

Marijuana Trafficking — Repeat Offenses (KRS 218A.1421)

A second or subsequent offense for marijuana trafficking involving less than 8 ounces is elevated from a Class A misdemeanor to a felony with a mandatory minimum of one year in prison.

Persistent Felony Offender Enhancements (KRS 532.080)

Kentucky's persistent felony offender (PFO) statute can significantly enhance sentences for repeat drug offenders:

• PFO Second Degree: Conviction of a felony after one prior felony conviction — the court may impose the next higher degree of felony sentence.
• PFO First Degree: Conviction of a felony after two or more prior felony convictions — the court may impose an enhanced sentence of 10-20 years (Class C or D felony) or 20 years to life (Class A or B felony).

Drug-Free Zone Enhancements (KRS 218A.1411)

Drug trafficking within 1,000 yards of a school, public housing project, or licensed day care center is punishable as a felony one class higher than the underlying trafficking offense.

Treatment Alternatives to Incarceration in Kentucky

Deferred Prosecution (KRS 218A.14151)

For first-degree possession offenses, deferred prosecution is the preferred alternative for first-time offenders. Under this program, prosecution is deferred while the defendant completes a substance abuse treatment program. Upon successful completion, charges may be dismissed.

Presumptive Probation

First and second offenses for possession of a controlled substance in the first degree are subject to presumptive probation, meaning the court presumes probation with treatment conditions rather than incarceration, unless the Commonwealth demonstrates reasons to deviate.

Pretrial Diversion (KRS 533.250-533.262)

Kentucky's pretrial diversion program for felony drug offenders allows eligible defendants to enter a supervised diversion program. Upon successful completion of all conditions — including substance abuse treatment, drug testing, and community service — the charges are dismissed.

Substance Abuse Treatment Programs (KRS 218A.275-218A.276)

• KRS 218A.275: Assessment and treatment program for first offenders convicted of possession of controlled substances.
• KRS 218A.276: Assessment and treatment program for persons convicted of possession of marijuana, synthetic cannabinoids, substituted cathinones, piperazines, or salvia.

Drug Court Programs (KRS 26A.400)

Drug courts provide a comprehensive, judicially supervised treatment program for eligible nonviolent offenders. Participants receive substance abuse treatment, mental health services, and vocational assistance as an alternative to traditional criminal prosecution and incarceration.

Casey's Law (KRS 222.430-222.437)

Kentucky's Casey's Law allows parents, relatives, or friends to petition the court for involuntary treatment of a person suffering from substance use disorder who is a danger to themselves or others. This is a civil process, not a criminal one, but provides a pathway to treatment outside the criminal justice system.

Recent Changes to Kentucky Drug Laws

Medical Cannabis Legalization — Senate Bill 47 (Effective January 1, 2025)

Kentucky legalized medical cannabis through Senate Bill 47, signed by Governor Beshear on March 31, 2023. The first dispensary sales began in late 2025, with three dispensaries open as of early 2026 in Louisville, Ferguson, and Beaver Dam. The program permits raw plant material for vaporization, edibles, oils, tinctures, and topicals but prohibits smoking.

House Bill 829 — Expedited Cannabis Licensing (2024)

The Kentucky legislature passed HB 829 to allow the Cabinet for Health and Family Services to begin issuing cannabis business licenses in 2024 rather than waiting until January 2025. The bill also added new restrictions on patient access, including additional requirements for the patient registry.

2024 Kentucky Acts Chapter 174 — Drug Penalty Amendments (Effective July 15, 2024)

This legislation amended KRS 218A.1415 (first-degree possession) and related trafficking statutes, updating penalty structures and classification criteria for certain controlled substance offenses.

Enhanced Fentanyl Provisions

Kentucky has strengthened penalties for fentanyl trafficking, requiring persons convicted of trafficking heroin, fentanyl, carfentanil, or fentanyl derivatives at the Class C felony level or higher to serve at least 50% of their sentence before becoming eligible for any form of early release.

Medical Cannabis Qualifying Conditions Expansion (2026)

In February 2026, the Office of Medical Cannabis submitted a recommendation to legislative leadership to expand the list of qualifying medical conditions for the medical cannabis program.